Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Jaguar Health, Inc.

NASDAQ: JAGXHealthcare / Biotechnology / USA
0.2700+0.0100+3.85%Vol 1 993 8891Y Perf -89.54%
Jan 18th, 2019 16:00
BID0.2600 ASK0.2700
Open0.2600 Previous Close0.2600
Pre-Market0.27 After-Trading-
 0.01 3.85%  - -%
Target Price
1.25 
Analyst Rating
— 0.00
Potencial %
362.96 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
     18.47
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
     32.69
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)18 
Earnings Rating
Neutral
Price Range Ratio 52wk %
2.31 
Earnings Date
18th Feb 2019

Today's Price Range

0.26000.3000

 

52wk Range

0.12006.60

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
22.73%
3 Months
-50.91%
6 Months
-76.11%
1 Year
-89.54%
3 Years
-99.41%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
JAGX0.27000.01003.85
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.10
Current Ratio
0.50
Long Term Debt to Total Capital
0.51
Total Debt to Equity
1.57
Interest Coverage
-14.70
Leverage Ratio 3.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
44.00
EBIT Margin
-873.30
EBITDA Margin
-844.70
Pre-tax Profit Margin
-
Profit Margin
-62.47
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
1.76
PS Ratios
6.44
Price to Cash Flow
-
Price to Free Cash Flow
-1.00
Cash Flow Per Share
-2.44
Price to Tangible Book
-0.67
Book Value per Share
0.16
Enterprise Value (in ths.)
33 696
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-601.74
ROE last 12 Months
-193.16
Return on Assets (5Y Avg)
-23.90
ROA last 12 Months
-76.70
Return on Capital (5Y Avg)
-321.65
ROC last 12 Months
-102.37
Return on invested Capital Q
-18.88
Return on invested Capital Y
-120.87
Assets Turnover
0.00
Receivables Turnover
1.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
2 820
Revenue per Share
0.04
Revenue Growth 3 Years
156.09
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2017-0.13-
Q02 2017-0.22-0.1245.45
Q01 2017--0.28-
Q03 2016-0.40-0.3025.00
Q02 2016-0.42-0.3516.67
Q01 2016-0.49-0.4312.24
Q03 2015-0.49-0.3626.53
Q02 2015--0.97-
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.130.00-
12/2017 QR-0.070.00-
12/2017 FY-0.17-142.86Negative
12/2018 FY-0.09-50.00Negative
Next Report Date18th Feb 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1 993 889
Shares Outstanding (in ths.)64 904
Trades Count1 382
Dollar Volume547 381
Avg. Volume709 696
Avg. Weekly Volume650 309
Avg. Monthly Volume597 127
Avg. Quarterly Volume533 233

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

57%43%

Bearish Bullish

54%46%

Bearish Bullish

54%46%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News